Pfizer is set to invest an additional $500m (£411m) to build an advanced gene therapy manufacturing facility in Sanford, North Carolina, US.
22 Aug 2019
17 Jul 2019
Kite, a Gilead Company (Nasdaq: GILD), today announced plans for a new 67,000-square-foot facility in Oceanside, California, dedicated to the development and manufacturing of viral vectors, a critical starting material in the production of cell therapies.
11 Jul 2019
US-based healthcare firm Nexus Pharmaceuticals is set to construct a new sterile injectable manufacturing facility in Wisconsin, US.
25 Jun 2019
20 Jun 2019
Gamida Cell and Lonza announced that the companies have entered into a strategic manufacturing agreement.
22 May 2019
WuXi Biologics, a global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has entered into a strategic partnership letter of intent (LOI) with a global vaccine leader, pursuant to which WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market.
21 May 2019
Catalent has wrapped up its $1.2bn acquisition of Maryland-based gene therapy contract development and manufacturing organisation (CDMO) Paragon Bioservices.
17 May 2019
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline plc (NYSE: GSK) for approximately €90 million in cash.
13 May 2019
Pfizer has announced the opening of a new 175,000 square-foot manufacturing facility in Andover, Massachusetts.
25 Apr 2019
Kite announces plans for new state-of-the-art facility to expand cell therapy production capabilities
Kite, a Gilead Company (Nasdaq: GILD), today announced plans for a new facility in Frederick County, Maryland, which will produce innovative cell therapies for people with cancer.